- Centers & Specialties
- Clinical Interests
- Breast cancer treatment
- High-risk patients
- Nipple sparing mastectomy
- Innovations in breast surgical techniques
- Medical Education
- MD, Harvard Medical School
- PhD, Harvard University
- Residency, Brigham and Women's Hospital
- Board Certifications
- Boston: Massachusetts General Hospital
- Insurances Accepted
- Aetna Health Inc.
- Beech Street
- Blue Cross Blue Shield - Blue Care 65
- Blue Cross Blue Shield - Indemnity
- Blue Cross Blue Shield - Managed Care
- Blue Cross Blue Shield - Partners Plus
- Cigna (PAL #'s)
- Fallon Community HealthCare
- Great-West Healthcare (formally One Health Plan)
- Harvard Pilgrim Health Plan - ACD
- Harvard Pilgrim Health Plan - PBO
- Health Care Value Management (HCVM)
- Humana/Choice Care PPO
- Medicare - ACD
- Neighborhood Health Plan - ACD
- Neighborhood Health Plan - PBO
- OSW - Maine
- OSW - New Hampshire
- OSW - Rhode Island
- Private Health Care Systems (PHCS)
- Railroad Medicare
- Railroad Medicare - ACD
- Senior Whole Health
- Tufts Health Plan
- United Healthcare (non-HMO) - ACD
- United Healthcare (non-HMO) - PBO
- Patient Age Group
Barbara L. Smith, MD, PhD. is the Director of the Breast Program and Co-Director of the Women's Cancers Program at Massachusetts General Hospital. She is an Associate Professor of Surgery at Harvard Medical School and at the MGH. Dr. Smith received her undergraduate training at Massachusetts Institute of Technology, an MD. from Harvard Medical School's Harvard/MIT Division of Health Sciences and Technology and a PhD from Harvard University Graduate School of Arts and Sciences. Dr. Smith's research activities have focused on reducing the extent of surgery and radiation required to treat breast cancer, diagnosis and treatment issues in young women with breast cancer, and three dimensional breast anatomy as it relates to breast surgery and pathologic analysis of specimens. She has been a Visiting Professor at Sun Yat-sen University in China since 2006 where she has assisted in development of multidisciplinary breast cancer programs and clinical research activities.
Dr. Smith was named one of Boston Magazine's Top Docs for 2013 for Breast Cancer.
- Research Summary
Nipple sparing mastectomy
High risk patients
Nipple-sparing mastectomy. Rusby JE, Smith BL, Gui GP. Br J Surg 2010 Mar;97(3);305-16.
An inferolateral approach to nipple-sparing mastectomy: optimizing mastectomy and reconstruction. Colwell AS, Gadd M, Smith BL, Austen WG Jr. Ann Plast Surg. 2010 Aug;65(2):140-3.
Occult nipple involvement in breast cancer: clinicopathologic findings in 316 consecutive mastectomy specimens. Brachte EF, Rusby Je, Michaelson JS, Chen LL, Muzikansky A, Smith BL, Koerner FC. J Clin Oncol 2009 Oct 20;27(30):4930-2
Development and validation of a model predictive of occult nipple involvement in women undergoing mastectomy. Rusby JE, Bracte EF, Othus M, Michaelson JS, Koerner FC, Smith, BL Br J Surg: 2008 Nov;95(11):1356-61
A new MGH study is one of the first to detail the outcomes of breast reconstruction surgery after having a nipple-sparing mastectomy, and this new, hard data, researchers say, is good news.
The Vaccine and Immunotherapy Center at Mass General focuses on locating the most promising research and safely accelerating its transformation into new lifesaving products.
55 Fruit St
Boston MA, 02114-2696
Phone 1: 617-726-6500